Lintuzumab-Ac225
LIN-AC225-AML03
Phase 2 mab active
Quick answer
Lintuzumab-Ac225 for Acute Myeloid Leukemia is a Phase 2 program (mab) at Actinium Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Actinium Pharmaceuticals
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 2
- Modality
- mab
- Status
- active